Skip to main content
Signal8

Mowry Anna

SEC insider (Form 3/4/5 filer). CIK 0001856938. CFO and Treasurer at Nautilus Biotechnology, Inc. (NAUT). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SEATTLE, WA.

Companies Mowry Anna has filed insider reports for

  • Nautilus Biotechnology, Inc. (NAUT): Officer, CFO and Treasurer
Mowry Anna profile photo

Mowry Anna

CIK: 0001856938

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nautilus Biotechnology, Inc. logo
NAUT

Nautilus Biotechnology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Nautilus Biotechnology, Inc. logo
    NAUT

    Nautilus Biotechnology, Inc.

    Mar 2, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    160K shares-
  • Nautilus Biotechnology, Inc. logo
    NAUT

    Nautilus Biotechnology, Inc.

    May 29, 2025
    Purchase
    Direct
    15K shares at avg. $0.77$11K
  • Nautilus Biotechnology, Inc. logo
    NAUT

    Nautilus Biotechnology, Inc.

    Mar 3, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    160K shares-

1-3 of 3